Mercado mundial de estimuladores magnéticos transcraneales: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

Los dispositivos de estimulación magnética transcraneal comprenden una bobina y un sistema para examinar y detectar los efectos de la terapia. Las bobinas utilizadas en la TMS son de diversos materiales, como una bobina compuesta de un material magnéticamente activo (diseño de núcleo sólido) o de un material magnéticamente inerte (diseño de núcleo de aire), según las variaciones y las características biofísicas necesarias. La creciente prevalencia de trastornos neurológicos, incluida la esquizofrenia y otros trastornos, y el aumento de la población geriátrica que conduce a un aumento de los trastornos cerebrales asociados con la edad están impulsando el mercado.

• Data Bridge Market Research analiza que se espera que el mercado de estimuladores magnéticos transcraneales crezca a una tasa de crecimiento anual compuesta (CAGR) del 8,90 % durante el período de pronóstico y es probable que alcance los USD 2258,71 millones al final del período de pronóstico. Se espera que el "estimulador magnético transcraneal repetitivo" sea el segmento de más rápido crecimiento, ya que se ha propuesto como el nuevo tratamiento para la depresión y la ansiedad, que permite la estimulación directa de volúmenes cerebrales más grandes y profundos (7-10). Es una forma no invasiva de estimulación cerebral y no requiere cirugía ni implantación de electrodos.

Definición de mercado

La estimulación magnética transcraneal (EMT) es un proceso no invasivo de estimulación cerebral que aplica fuerzas de inducción magnéticas en una zona crítica del cerebro. La inducción electromagnética se produce a partir de una bobina que utiliza electricidad y estos pulsos pasan por el cráneo hasta su zona receptora específica en el cerebro. Existen muchos métodos diferentes de estimulación cerebral, como la terapia electroconvulsiva y las técnicas de estimulación cerebral profunda; sin embargo, actualmente, la técnica de estimulación magnética transcraneal (EMT) es el método más ampliamente adoptado.

Dinámica del mercado de estimuladores magnéticos transcraneales

Conductores

• Aumento de casos de esquizofrenia

La esquizofrenia es una enfermedad en la que el paciente ve algunas cosas que le asustan y recientemente los casos de esquizofrenia están aumentando y están impulsando el mercado.

• Aumento del envejecimiento de la población

El número de personas mayores está aumentando y ahora forman parte de la población actual y están impulsando el mercado.

Además, la creciente conciencia sobre el estimulador magnético transcraneal entre los profesionales y el avance tecnológico en los dispositivos de estimulación magnética transcraneal afectan positivamente al mercado de estimuladores magnéticos transcraneales.

Oportunidades

Además, la creciente incidencia de trastornos neurológicos, como la enfermedad de Alzheimer y la enfermedad de Parkinson (EP), expandirá aún más la tasa de crecimiento del mercado de estimuladores magnéticos transcraneales en el futuro. 

Restricciones/Desafíos

On the other hand, growing shift towards electroconvulsive therapy are expected to obstruct market growth. Also, Hhgh price and lack of care are projected to challenge the transcranial magnetic stimulator market in the forecast period of 2022-2029.

This transcranial magnetic stimulator market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transcranial magnetic stimulator market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Transcranial Magnetic Stimulator Market

The contagious coronavirus has a potential economic impact and implications on most of the sectors, including the medical device industries. Governments worldwide are now responding to the threat of COVID-19 with all the essential measures, such as social distancing, travel restrictions, and large-scale quarantines that are anticipated to impact the businesses and consumer spending negatively. The outbreak of COVID-19, resulted in decreased public mobility and have also impacted the therapeutic and surgical industry significantly, as the surgical procedures and screening programs, which are non-immediate and are being postponed to decrease the burden on healthcare infrastructure.  Transcranial magnetic stimulator is a very complicated process that needs proper doctors and team to complete the process and because of COVID-19 it is making impossible to maintain a proper environment because of strict COVID-19 guidelines.

Recent Development

• In August 2020, MagVenture TMS Therapy received FDA clearance for the adjunct treatment of Obsessive compulsive disorder (OCD). It is the second indication in the US for the Danish medical device company MagVenture .

Global Transcranial Magnetic Stimulator Market Scope

The transcranial magnetic stimulator market is segmented on the basis of type, application, age group and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Deep transcranial magnetic stimulator
• Repetitive transcranial magnetic stimulator
• Others

On the basis of type, the transcranial magnetic stimulator market is segmented into deep transcranial magnetic stimulator, repetitive transcranial magnetic stimulator and others.

Application

• Alzheimer’s disease
• Depression
• Disease
• Epilepsy
• Other

Based on application, the transcranial magnetic stimulators market is segmented into Alzheimer’s disease, depression, Parkinson’s disease, epilepsy and others.

Age Group

• Adults
• Children

Basis of age group, the transcranial magnetic stimulators market is segmented into adults and children

End- users

• Research
• Diagnostics
• Therapeutics

On the basis of end- users, the transcranial magnetic stimulator market is segmented into research, diagnostics and therapeutics

Transcranial Magnetic Stimulator Market Regional Analysis/Insights

The transcranial magnetic stimulator market is analysed and market size insights and trends are provided by country, type, age group, application and end user as referenced above.

The countries covered in the transcranial magnetic stimulator market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transcranial magnetic stimulator market due to availability of skilled and trained professionals, favourable reimbursement policies and increasing adoption of advanced products within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to increasing government initiatives and growing medical tourism in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The transcranial magnetic stimulator market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transcranial magnetic stimulator market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transcranial magnetic stimulator market. The data is available for historic period 2010-2020.

Competitive Landscape and Transcranial Magnetic Stimulator Market Share Analysis

El panorama competitivo del mercado de estimuladores magnéticos transcraneales proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de estimuladores magnéticos transcraneales.

Algunos de los principales actores que operan en el mercado de estimuladores magnéticos transcraneales son eNeura Inc., MagVenture A/S, Neurosoft, Brainsway, The Magstim Company Limited, MAG & More GmbH, Neuronetics, Nexstim, Axilum Robotics, neuroCare Group GmbH, Zimmer Biomet, Bioventus, Synergy Orthopedics, Ito Co., Ltd., DePuy Synthes, DJO Global, Ossatec Benelux BV, Orchid Medical Centre, TERUMO BCT, INC., Isto Biologics, Arthrex, Inc., Smith & Nephew, Stryker, Medtronic, Orthofix Holdings, Inc., Ember Therapeutics, entre otros.

SKU-51805